Skip to main content

Technology

By Jessica Hagen | 08:00 am | February 11, 2026
The partnership will allow Mira's hormone test results to be compared with Oura Ring data on sleep, temperature and readiness, enabling trend tracking.
By Adam Ang | 07:35 pm | February 10, 2026
A community trial has shown that the data-driven, fall-detecting wearable robot developed at Nanyang Technological University requires less physiotherapist assistance.
By Adam Ang | 07:30 pm | February 10, 2026
Powered by conversational AI, the tool aims to plug Hong Kong's palliative care workforce gap – with fewer than one specialist per 100,000 people – as advance medical directive legislation takes effect in May 2026.
By Jessica Hagen | 01:44 pm | February 10, 2026
The California-based company will use the funds to expand its healthcare advocate network and platform, partnerships with payers and providers and for clinical research.
Emerging Technologies
By Jessica Hagen | 12:21 pm | February 10, 2026
Debra Beauregard, director of medical intelligence and innovation at San Diego-based Rady Children's Health, joins MobiHealthNews to discuss partnering with digital health companies.
Emerging Technologies
By HIMSS TV | 10:01 am | February 10, 2026
Debra Beauregard, director of medical intelligence and innovation at Rady Children’s Health, discusses why some hospitals are cautious about exploring new technologies and how her team evaluates technology solutions to pilot and scale.
By Jessica Hagen | 04:33 pm | February 09, 2026
The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain barrier to help treat neurodegenerative diseases.
By Jessica Hagen | 01:40 pm | February 09, 2026
The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.
By Adam Ang | 07:01 pm | February 08, 2026
Also, Omniscient Neurotechnology has received $14 million in government-backed funding to scale its AI-based brain mapping platform.
By Jessica Hagen | 03:37 pm | February 06, 2026
A federal jury found that Medtronic, which plans to appeal the ruling, unlawfully monopolized the bipolar surgical device market through anticompetitive bundling and exclusive-deal practices that harmed rival Applied Medical.